Soroku Yagihashi

发表

Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients

S. Yagihashi, R. Wada, S. Yagihashi, 2002, Diabetologia.

Glucotoxic Mechanisms and Related Therapeutic Approaches.

S. Yagihashi, Soroku Yagihashi, 2016, International review of neurobiology.

Effects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy

R. Wada, S. Yagihashi, M. Takeuchi, 2001, European journal of clinical investigation.

Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models.

S. Yagihashi, Soroku Yagihashi, 1997, Journal of the peripheral nervous system : JPNS.

Thickening of glomerular basement membrane in spontaneously diabetic rats

S. Yagihashi, Y. Gotō, N. Kaseda, 1978, Diabetologia.

Immunohistochemical demonstration of somatostatin-containing cells in the human placenta.

S. Yagihashi, M. Nishihira, Soroku Yagihashi, 1978, The Tohoku journal of experimental medicine.

Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats.

S. Yagihashi, M. Kamijo, K. Watanabe, 1990, The American journal of pathology.

Only limited effects of aminoguanidine treatment on peripheral nerve function, (Na+,K+)-ATPase activity and thrombomodulin expression in streptozotocin-induced diabetic rats

R. Wada, S. Yagihashi, M. Nakano, 1999, Diabetologia.

Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab)

R. Dobrowsky, N. Calcutt, G. Biessels, 2014, Journal of the peripheral nervous system : JPNS.

Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine

R. Wada, S. Yagihashi, J. Satoh, 1996, Diabetologia.

Increased in situ expression of nitric oxide synthase in human colorectal cancer

S. Yagihashi, Y. Ebina, N. Yagihashi, 2000, Virchows Archiv.